A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway. The blood test is currently offered under the brand name COLVERA® in the US as a tool to aid in the detection of cancer relapse after treatment.
[Flinders University]
7992332
{7992332:nan}
1
apa
50
default
1
164167
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News